Literature DB >> 23315215

Quantum chemical study of silanediols as metal binding groups for metalloprotease inhibitors.

Igor S Ignatyev1, Manuel Montejo, Pilar Gema Rodríguez Ortega, Juan Jesús López González.   

Abstract

DFT (B3LYP and M06L) as well as ab initio (MP2) methods with Dunning cc-pVnZ (n=2,3) basis sets are employed for the study of the binding ability of the new class of protease inhibitors, i.e., silanediols, in comparison to the well-known and well-studied class of inhibitors with hydroxamic functionality (HAM). Active sites of metalloproteases are modeled by [R₃M-OH₂]²⁺ complexes, where R stands for ammonia or imidazole molecules and M is a divalent cation, namely zinc, iron or nickel (in their different spin states). The inhibiting activity is estimated by calculating Gibbs free energies of the water displacement by metal binding groups (MBGs) according to: [R₃M-OH₂]²⁺ + MBG → [R₃M-MBG]²⁺ + H₂O. The binding energy of silanediol is only a few kcal mol(-1) inferior to that of HAM for zinc and iron complexes and is even slightly higher for the triplet state of the (NH₃)₃Ni²⁺ complex. For both MBGs studied in the ammonia model the binding ability is nearly the same, i.e., Fe²⁺(t) > Ni²⁺(t) > Fe²⁺(q) > Ni²⁺(s) > Zn²⁺. However, for the imidazole model the order is slightly different, i.e., Ni²⁺(t) > Fe²⁺(t) > Fe²⁺(q) > Ni²⁺(s) ≥ Zn²⁺. Equilibrium structures of the R₃Zn ²⁺ complexes with both HAM and silanediol are characterized by the monodentate binding, but the bidentate character of binding increases on going to iron and nickel complexes. Two types of intermediates of the water displacement reactions for [(NH₃)₃M-OH₂]²⁺ complexes were found which differ by the direction of the attack of the MBG. Hexacoordinated complexes exhibit bidentate bonding of MBGs and are lower in energy for M=Ni and Fe. For Zn penta- and hexacoordinated complexes have nearly the same energy. Intermediate complexes with imidazole ligands have only octahedral structures with bidentate bonding of both HAM and dimethylsilanediol molecules.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23315215     DOI: 10.1007/s00894-012-1745-0

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  42 in total

1.  The history of inhibitors of angiotensin converting enzyme.

Authors:  J R Vane
Journal:  J Physiol Pharmacol       Date:  1999-12       Impact factor: 3.011

2.  Unexpected deacetylation mechanism suggested by a density functional theory QM/MM study of histone-deacetylase-like protein.

Authors:  Clémence Corminboeuf; Po Hu; Mark E Tuckerman; Yingkai Zhang
Journal:  J Am Chem Soc       Date:  2006-04-12       Impact factor: 15.419

3.  Density functional theory for transition metals and transition metal chemistry.

Authors:  Christopher J Cramer; Donald G Truhlar
Journal:  Phys Chem Chem Phys       Date:  2009-10-21       Impact factor: 3.676

Review 4.  15 years of heart-failure trials: what have we learned?

Authors:  B M Massie
Journal:  Lancet       Date:  1998-08       Impact factor: 79.321

5.  Mechanistically significant diastereoselection in the sulfoximine inhibition of carboxypeptidase A.

Authors:  W L Mock; J Z Zhang
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

Review 6.  Inside HDAC with HDAC inhibitors.

Authors:  Philippe Bertrand
Journal:  Eur J Med Chem       Date:  2010-02-14       Impact factor: 6.514

Review 7.  Angiotensin II receptor antagonists.

Authors:  M Burnier; H R Brunner
Journal:  Lancet       Date:  2000-02-19       Impact factor: 79.321

8.  Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.

Authors:  John R Somoza; Robert J Skene; Bradley A Katz; Clifford Mol; Joseph D Ho; Andy J Jennings; Christine Luong; Andrew Arvai; Joseph J Buggy; Ellen Chi; Jie Tang; Bi-Ching Sang; Erik Verner; Robert Wynands; Ellen M Leahy; Douglas R Dougan; Gyorgy Snell; Marc Navre; Mark W Knuth; Ronald V Swanson; Duncan E McRee; Leslie W Tari
Journal:  Structure       Date:  2004-07       Impact factor: 5.006

9.  Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor.

Authors:  Alessandro Vannini; Cinzia Volpari; Gessica Filocamo; Elena Caroli Casavola; Mirko Brunetti; Debora Renzoni; Prasun Chakravarty; Chantal Paolini; Raffaele De Francesco; Paola Gallinari; Christian Steinkühler; Stefania Di Marco
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-11       Impact factor: 11.205

10.  Silicon-based metalloprotease inhibitors: synthesis and evaluation of silanol and silanediol peptide analogues as inhibitors of angiotensin-converting enzyme.

Authors:  Mwangi wa Mutahi; Thomas Nittoli; Luxuan Guo; Scott McN Sieburth
Journal:  J Am Chem Soc       Date:  2002-06-26       Impact factor: 15.419

View more
  1 in total

1.  Study of the chelating properties of Ge(OH)2 functionality as metal binding group for Zn2+ cation in simplified protease-like environments: a DFT analysis.

Authors:  Pilar Gema Rodríguez Ortega; Manuel Montejo; Juan Jesús López González
Journal:  J Mol Model       Date:  2014-08-22       Impact factor: 1.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.